18 Jun 2018 16:39
Β
18 June 2018
Accrol Group Holdings plc
(AIM: ACRL)Β
Β
Director's Dealing
Β
Accrol Group Holdings plc (the "Company" or "Accrol"), the AIM-listed leading independent tissue converter,Β is pleased to announce that, Joanne Lake, a Non-Executive Director of Accrol, has purchased 6,053 ordinary shares of Β£0.001 each ("Ordinary Shares") at a price of 25.95p per Ordinary Share as set out below:
Β
Β Β Name | Β Β Β Title | Β Β Number of Shares | Β Β Value of Shares | Β Β Resulting Shareholding | Percentage of Issued Share Capital |
Joanne Lake | Non-Executive Director | 6,053 | Β£1,570.75 | 74,386 | 0.038% |
Β
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Β
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
Β
1 | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Joanne Lake | |
2 | Reason for the notification | ||
a) | Position/status | Non-Executive Director Β | |
b) Β | Initial notification /Amendment | Initial notification | |
3 Β | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Accrol Group Holdings plc | |
b) | LEI | 213800MC56M5G69RJ226 | |
4 Β | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) Β | Description of the financial instrument, type of instrument Identification code | Ordinary shares of Β£0.001 Β ISIN: GB00BZ6VT592 | |
b) | Nature of the transaction | Purchase of Ordinary Shares | |
c) | Price(s) and volume(s) | Price(s) 25.95p Β | Volume(s) 6,053 |
d) | Aggregated information - Aggregated volume - Price | N/A - single transaction | |
e) | Date of the transaction | 18 June 2017 | |
f) | Place of the transaction | London Stock Exchange, AIM | |
Β
Enquiries:
Β
For further information, please contact: | Β |
Β | Β |
Accrol Group Holdings plc | Β |
Gareth Jenkins, Chief Executive Officer | +44 (0) 1254 278 844 |
Steve Townsley, Chief Finance Officer | +44 (0) 1254 278 844 |
Β | Β |
Zeus Capital Limited (Nominated Adviser & Broker)Β | Β |
Dan Bate / Andrew Jones | +44 (0) 161 831 1512 |
Dominic King / John Goold | +44 (0) 203 829 5000 |
Β | Β |
Belvedere Communications Limited | Β |
Cat Valentine (cvalentine@belvederepr.com) | +44 (0) 7715 769 078 |
Llew Angus (langus@belvederepr.com) | +44 (0) 7407 023 147 |
Β
Notes to Editors
Β
Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK.Β
Β
Accrol operates from three sites:
Β
Β· A manufacturing, storage and distribution facility in Blackburn;
Β· A facial tissue plant, also in Blackburn; and
Β· A manufacturing, storage and distribution facility in Leyland.
Β
Β
Follow the stocks